DK1359939T3 - Sammensætning og fremgangsmåde til potensering af lægemidler - Google Patents
Sammensætning og fremgangsmåde til potensering af lægemidlerInfo
- Publication number
- DK1359939T3 DK1359939T3 DK01273668T DK01273668T DK1359939T3 DK 1359939 T3 DK1359939 T3 DK 1359939T3 DK 01273668 T DK01273668 T DK 01273668T DK 01273668 T DK01273668 T DK 01273668T DK 1359939 T3 DK1359939 T3 DK 1359939T3
- Authority
- DK
- Denmark
- Prior art keywords
- potentiation
- drugs
- composition
- drug
- effective amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/775,794 US6833377B2 (en) | 2001-02-05 | 2001-02-05 | Composition and method for potentiating drugs |
PCT/IB2001/002566 WO2002062388A1 (en) | 2001-02-05 | 2001-12-19 | Composition and method for potentiating drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1359939T3 true DK1359939T3 (da) | 2007-02-26 |
Family
ID=25105521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01273668T DK1359939T3 (da) | 2001-02-05 | 2001-12-19 | Sammensætning og fremgangsmåde til potensering af lægemidler |
Country Status (11)
Country | Link |
---|---|
US (1) | US6833377B2 (de) |
EP (1) | EP1359939B1 (de) |
AT (1) | ATE343399T1 (de) |
AU (1) | AU2002219417B2 (de) |
CA (1) | CA2437351A1 (de) |
DE (1) | DE60124144T2 (de) |
DK (1) | DK1359939T3 (de) |
ES (1) | ES2275624T3 (de) |
IL (2) | IL157226A0 (de) |
PT (1) | PT1359939E (de) |
WO (1) | WO2002062388A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050192220A1 (en) * | 2001-02-05 | 2005-09-01 | Gevys Pharmaceuticas Ltd. | Composition and method for potentiating drugs |
TW200800142A (en) * | 2005-09-09 | 2008-01-01 | Univ Manitoba | Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
US9877921B2 (en) | 2005-09-09 | 2018-01-30 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
US20160045457A1 (en) | 2005-09-09 | 2016-02-18 | Ousama Rachid | Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine |
US20070293582A1 (en) * | 2006-06-05 | 2007-12-20 | Malcolm Hill | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
US20070293581A1 (en) * | 2006-06-05 | 2007-12-20 | Malcolm Hill | Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies |
US20080108970A1 (en) * | 2006-11-08 | 2008-05-08 | Viertio-Oja Hanna E | Control of Drug Administration |
US8729070B2 (en) * | 2008-02-20 | 2014-05-20 | Targia Pharmaceuticals | CNS pharmaceutical compositions and methods of use |
WO2009104080A2 (en) * | 2008-02-20 | 2009-08-27 | Targia Pharmaceuticals | Cns pharmaceutical compositions and methods of use |
US20120322884A1 (en) | 2010-03-01 | 2012-12-20 | University Of Manitoba | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
US20140242177A1 (en) | 2011-10-21 | 2014-08-28 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
CA2876883C (en) | 2012-06-15 | 2022-11-01 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
PT2976072T (pt) | 2013-03-22 | 2021-08-12 | Univ Nova Southeastern | Partículas finas de epinefrina e métodos de utilização das mesmas para o tratamento de afeções que reagem à epinefrina |
WO2016027259A1 (en) * | 2014-08-21 | 2016-02-25 | Targia Pharmaceuticals | Cns pharmaceutical compositions and methods of use |
CN110325214A (zh) * | 2016-12-22 | 2019-10-11 | Rvx疗法有限公司 | 用于预防和治疗神经元损伤的低剂量药物组合 |
WO2020188457A1 (en) * | 2019-03-15 | 2020-09-24 | Ftf Pharma Private Limited | Solutions for oral dosage |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947579A (en) | 1974-06-03 | 1976-03-30 | Nelson Research & Development Company | Method and composition for potentiating neuroleptic drugs |
DE3321969A1 (de) | 1983-06-18 | 1984-12-20 | Troponwerke GmbH & Co KG, 5000 Köln | 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4843071A (en) | 1986-12-05 | 1989-06-27 | Serotonin Industries Of Charleston | Method and composition for treating obesity, drug abuse, and narcolepsy |
US4788189A (en) | 1988-02-29 | 1988-11-29 | Glazer Howard I | Method to treat smoking withdrawal symptoms by potentiated central noradrenergic blocking |
US5431922A (en) | 1991-03-05 | 1995-07-11 | Bristol-Myers Squibb Company | Method for administration of buspirone |
US5891842A (en) | 1993-04-09 | 1999-04-06 | Trustees Of Tufts College | Methodology for eliciting an analgesic response in a living subject |
CA2134038C (en) | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
FR2725623A1 (fr) | 1994-10-18 | 1996-04-19 | Flamel Tech Sa | Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os |
EP0714663A3 (de) | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten |
US5942241A (en) | 1995-06-09 | 1999-08-24 | Euro-Celtique, S.A. | Formulations and methods for providing prolonged local anesthesia |
ATE236158T1 (de) * | 1999-11-12 | 2003-04-15 | Neurogen Corp | Bicyclische und tricyclische heteroaromatische verbindungen |
-
2001
- 2001-02-05 US US09/775,794 patent/US6833377B2/en not_active Expired - Lifetime
- 2001-12-19 CA CA002437351A patent/CA2437351A1/en not_active Abandoned
- 2001-12-19 AU AU2002219417A patent/AU2002219417B2/en not_active Ceased
- 2001-12-19 WO PCT/IB2001/002566 patent/WO2002062388A1/en active IP Right Grant
- 2001-12-19 ES ES01273668T patent/ES2275624T3/es not_active Expired - Lifetime
- 2001-12-19 IL IL15722601A patent/IL157226A0/xx unknown
- 2001-12-19 DK DK01273668T patent/DK1359939T3/da active
- 2001-12-19 AT AT01273668T patent/ATE343399T1/de not_active IP Right Cessation
- 2001-12-19 EP EP01273668A patent/EP1359939B1/de not_active Expired - Lifetime
- 2001-12-19 PT PT01273668T patent/PT1359939E/pt unknown
- 2001-12-19 DE DE60124144T patent/DE60124144T2/de not_active Expired - Lifetime
-
2003
- 2003-08-04 IL IL157226A patent/IL157226A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2437351A1 (en) | 2002-08-15 |
EP1359939B1 (de) | 2006-10-25 |
AU2002219417B2 (en) | 2007-03-22 |
US6833377B2 (en) | 2004-12-21 |
DE60124144T2 (de) | 2007-09-06 |
IL157226A0 (en) | 2004-02-19 |
PT1359939E (pt) | 2007-02-28 |
US20030004134A1 (en) | 2003-01-02 |
DE60124144D1 (de) | 2006-12-07 |
ES2275624T3 (es) | 2007-06-16 |
WO2002062388A1 (en) | 2002-08-15 |
ATE343399T1 (de) | 2006-11-15 |
EP1359939A1 (de) | 2003-11-12 |
IL157226A (en) | 2010-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1359939T3 (da) | Sammensætning og fremgangsmåde til potensering af lægemidler | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
MXPA03008756A (es) | Derivados de n-(arilsulfonil) beta-aminoacidos que comprenden un grupo aminometilo substituido, el metodo de preparacion de los mismos y las composiciones farmaceuticas que los contienen. | |
NO20061925L (no) | Farmasoytiske preparater for forebyggelse av overdose eller misbruk | |
HK1076605A1 (en) | Formulations | |
HK1096034A1 (en) | A solid dosage form comprising a fibrate | |
DK0738152T3 (da) | Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer | |
WO2002074247A3 (en) | Pharmaceutical formulations for sustained release | |
EA200700362A1 (ru) | Конъюгат, содержащий антивирусное соединение, в частности ингибирующее вич, фармацевтическая композиция и набор стандартной дозы лекарственного препарата на его основе, способ ингибирования с его помощью | |
MXPA06011467A (es) | Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid). | |
HUP0302857A2 (hu) | Gyógyszerészeti kiszerelés | |
TR199800631A2 (xx) | Ecza form�lasyonu. | |
MXPA02002249A (es) | Composiciones farmaceuticas agradables al paladar para animales de compania. | |
WO2005117895A8 (en) | Compositions comprising meloxicam | |
CY1113462T1 (el) | Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο | |
BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
WO2005004915A3 (en) | Compositions comprising meloxicam | |
ATE342264T1 (de) | Indolderivate und deren verwendung als gnrh antagonisten | |
WO2007011958A3 (en) | Intraoral dosage forms of glucagon | |
WO2001074790A3 (en) | Novel compounds for enhancing chemotherapy | |
SI1596841T1 (sl) | Terapevtski sistem amoksicilina in klavulanske kisline | |
ATE460934T1 (de) | Pharmazeutische zubereitungen von ciprofloxacin | |
ATE389402T1 (de) | Sedierende nicht-benzodiazepin-formulierungen | |
WO2004087880A8 (en) | Compounds and their use to treat diabetes and related disorders | |
TR200301553A1 (tr) | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |